Market closed
Prestige Consumer Healthcare/$PBH
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Prestige Consumer Healthcare
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Ticker
$PBH
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
570
Website
PBH Metrics
BasicAdvanced
$3.9B
Market cap
19.20
P/E ratio
$4.10
EPS
0.47
Beta
-
Dividend rate
Price and volume
Market cap
$3.9B
Beta
0.47
52-week high
$84.65
52-week low
$57.95
Average daily volume
297K
Financial strength
Current ratio
3.561
Quick ratio
2.012
Long term debt to equity
61.107
Total debt to equity
61.26
Interest coverage (TTM)
5.68%
Management effectiveness
Return on assets (TTM)
6.12%
Return on equity (TTM)
12.61%
Valuation
Price to earnings (TTM)
19.2
Price to revenue (TTM)
3.528
Price to book
2.25
Price to tangible book (TTM)
-3.49
Price to free cash flow (TTM)
15.389
Growth
Revenue change (TTM)
-1.45%
Earnings per share change (TTM)
-348.47%
3-year revenue growth (CAGR)
2.81%
3-year earnings per share growth (CAGR)
5.01%
What the Analysts think about PBH
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Prestige Consumer Healthcare stock.
PBH Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
PBH Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
PBH News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Prestige Consumer Healthcare stock?
Prestige Consumer Healthcare (PBH) has a market cap of $3.9B as of December 22, 2024.
What is the P/E ratio for Prestige Consumer Healthcare stock?
The price to earnings (P/E) ratio for Prestige Consumer Healthcare (PBH) stock is 19.2 as of December 22, 2024.
Does Prestige Consumer Healthcare stock pay dividends?
No, Prestige Consumer Healthcare (PBH) stock does not pay dividends to its shareholders as of December 22, 2024.
When is the next Prestige Consumer Healthcare dividend payment date?
Prestige Consumer Healthcare (PBH) stock does not pay dividends to its shareholders.
What is the beta indicator for Prestige Consumer Healthcare?
Prestige Consumer Healthcare (PBH) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.